Lavo AI: Accelerating Drug Development with AI-Powered Crystal Structure Prediction

Lavo AI is an AI-powered platform developed by Lavo Life Sciences, designed to streamline and enhance drug development through advanced crystal structure prediction. By leveraging cutting-edge AI models and computational chemistry, Lavo AI helps pharmaceutical companies de-risk pipelines, optimize solid-state formulations, and avoid costly late-stage surprises. The tool caters to researchers, scientists, and pharmaceutical professionals seeking efficient solutions for crystallographic analysis and drug discovery.

Key Features:

• Crystal Console: A web-based platform for structure analysis, virtual polymorph screening, and PXRD analysis.
• High-Throughput Virtual Screening: Efficiently identify and compare crystal structures.
• 3D Visualization: Interactive tools for analyzing molecular arrangements.
• Quantum Mechanical Calculations: Advanced simulations for accurate predictions.
• Cloud-Based High-Performance Computing: Scalable resources for complex analyses.
• Contract Research Services: Expert-led support for customized protocols and detailed reporting.
• Proprietary AI Models: Lavo-NN, a neural network potential for precise molecule crystal energy predictions.

Pricing:

Lavo AI offers flexible solutions, including self-service platforms and contract research services, with pricing tailored to specific needs and projects.

Conclusion:

Lavo AI is a transformative tool for pharmaceutical research, combining AI and computational chemistry to revolutionize drug development processes and reduce time-to-market for critical therapies.